Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
390.00    -1.00 (-0.26%)
Bid:
390.00
Ask:
392.00
Spread: 2.00 (0.513%)
Market Cap: £498.18m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Interim Management Statement

19 Dec 2012 13:11

RNS Number : 9259T
North Atlantic Smlr Co Inv Tst PLC
19 December 2012
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2012

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2012 to 31 October 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

 

Cumulative performance

As at

31 October 2012

3 months %

6 months %

1 year %

3 years %

5 years %

NAV *

Basic

1,643p

4.7

3.2

3.9

19.2

(6.3)

Diluted

1,482p

4.6

4.9

5.5

36.0

13.0

Mid-market price

1,151p 

14.0

2.8

17.5

47.3

(3.8)

Discount to diluted NAV *

22.3% 

Standard & Poor's 500 Composite Index **

875.5

(0.5)

1.7

12.4

39.0

17.5

Russell 2000 **

507.6

2.3

0.9

10.2

48.4

27.5

FTSE All-Share Index

3,024.4

3.3

1.3

5.7

17.0

(12.4)

US Dollar/Sterling exchange rate

1.6111

(2.8)

0.8

0.2

2.3

22.5

 

* Excluding retained revenue for the period.

** Sterling adjusted.

 

Material Events and Transactions during the Period

 

There have been no material events or transactions during the quarter ended 31 October 2012.

 

Transaction in Own Shares

 

No shares have been bought back in the quarter being reported.

 

  

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2012

 

% of portfolio 

Oryx International Growth Fund Limited *

UK Listed

10.2

Bionostics Holdings Ltd

US Unquoted

7.8

MJ Gleeson Group

UK Listed

7.0

Hampton Investment Properties Limited

UK Unquoted

6.3

US Treasury Bills

US Treasury Bills

6.2

Trident Private Equity Fund III LLP

UK Unquoted

5.6

Guinness Peat Group

New Zealand Listed

5.4

BBA Aviation Group

UK Listed

4.5

Bioquell

UK Listed

4.0

RPC Group

 

UK Listed

 

4.0

 

% of total portfolio

61.0

 

* Incorporated in Guernsey

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2012

 

United 

United 

New

States 

Kingdom 

Europe 

Zealand

Total 

Investment Companies

0.4

18.1

18.5

Manufacturing

7.8

7.8

Real Estate

8.9

0.4

9.3

General Industrials

1.0

4.0

5.0

Health Care, Equipment & Services

7.4

6.9

14.3

Support Services

1.5

6.2

7.7

Transportation

4.5

4.5

General Financials

4.5

4.5

Media

1.4

1.4

Construction & Materials

7.0

7.0

Technology Hardware & Equipment

 1.7

1.7

Travel & Leisure

1.3

1.3

Oil & Gas Producers

1.2

0.6

1.8

General Retailers

3.6

3.6

Financial Services

5.4

5.4

25.5

62.5

0.4

5.4

93.8

Treasury bills

6.2

6.2

Total at 31 October 2012

31.7

62.5

0.4

5.4

100.0

Total at 31 January 2012

30.1

63.6

0.5

5.8

100.0

 

 

The financial information for the period ended 31 October 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

 

19th December 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMMMZFLGGZZM
Date   Source Headline
6th Aug 20259:57 amRNSTransaction in Own Shares and TVR
15th Jul 20259:34 amRNSNet Asset Value(s)
7th Jul 20251:00 pmRNSTransaction in Own Shares and TVR
7th Jul 202511:34 amRNSTransaction in Own Shares and TVR
19th Jun 20259:51 amRNSTransaction in Own Shares nad TVR
13th Jun 20253:52 pmRNSNet Asset Value(s)
12th Jun 20251:50 pmRNSShare Split and Total Voting Rights
12th Jun 20251:46 pmRNSResult of AGM
9th Jun 202510:45 amRNSTransaction in Own Shares and TVR
2nd Jun 20251:15 pmRNSTransaction in Own Shares and TVR
30th May 202511:01 amRNSTransaction in Own Shares and TVR
27th May 20253:26 pmRNSTransaction in Own Shares and TVR
23rd May 20251:44 pmRNSCompany Secretary Change
16th May 20257:00 amRNSNet Asset Value(s)
15th May 20257:00 amRNSAnnual Financial Report & Notice of AGM
7th May 20257:00 amRNSFinal Results
16th Apr 20257:00 amRNSNet Asset Value(s)
3rd Apr 202510:35 amRNSTransaction in Own Shares and TVR
31st Mar 20259:44 amRNSTransaction in Own Shares and TVR
24th Mar 20259:13 amRNSTransaction in Own Shares and TVR
18th Mar 20253:15 pmRNSNet Asset Value(s)
3rd Mar 20252:17 pmRNSTransaction in Own Shares and TVR
27th Feb 20257:00 amRNSDividend Declaration
17th Feb 202512:49 pmRNSTransaction in Own Shares and TVR
14th Feb 20259:26 amRNSNet Asset Value(s)
10th Feb 202511:05 amRNSTransaction in Own Shares and TVR
15th Jan 202511:10 amRNSDirector Declaration
15th Jan 202511:01 amRNSDirector Declaration
15th Jan 202510:39 amRNSNet Asset Value(s)
12th Dec 20241:48 pmRNSNet Asset Value(s)
29th Nov 202411:57 amRNSTransaction in Own Shares
25th Nov 202410:10 amRNSTransaction in Own Shares
15th Nov 202410:57 amRNSNet Asset Value(s)
11th Nov 202410:30 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 202411:50 amRNSNet Asset Value(s)
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 202411:51 amRNSInvestment Update: Performance Chemicals
3rd Oct 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSHalf-year Report - Replacement
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNet Asset Value(s)
14th Aug 202410:40 amRNSNet Asset Value(s)
26th Jul 202410:20 amRNSTransaction in Own Shares
25th Jul 202411:08 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20243:35 pmRNSTransaction in Own Shares
11th Jul 20247:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.